| Literature DB >> 24973459 |
Danuta M Skowronski1, Catharine Chambers2, Suzana Sabaiduc1, Naveed Z Janjua1, Guiyun Li2, Martin Petric1, Mel Krajden1, Dale Purych3, Yan Li4, Gaston De Serres5.
Abstract
To understand the epidemic resurgence of influenza due to the 2009 pandemic influenza A(H1N1) strain (A[H1N1]pdm09) during the 2013-2014 influenza season, we compared age-related cross-sectional estimates of seroprotection before the pandemic (during 2009) and after the pandemic (during 2010 and 2013) to subsequent surveillance-based, laboratory-confirmed incidence of influenza due to A(H1N1)pdm09 in British Columbia, Canada. Prepandemic seroprotection was negligible except for very old adults (defined as adults aged ≥ 80 years), among whom 80% had seroprotection. Conversely, postpandemic seroprotection followed a U-shaped distribution, with detection in approximately 35%-45% of working-aged adults but in ≥ 70% of very old adults and young children, excluding children aged <5 years in 2013, among whom seroprotection again decreased to <20%. The incidence was 5-fold higher during 2013-2014, compared with 2010-2011, and was highest among children aged <5 years and working-aged adults, reflecting a mirror image of the age-based seroprotection data.Entities:
Keywords: A(H1N1)pdm09; hemagglutination inhibition; incidence; influenza; seroprotection; serosurvey; surveillance
Mesh:
Substances:
Year: 2014 PMID: 24973459 DOI: 10.1093/infdis/jiu366
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226